Last updated: June 5, 2026

Back to directory

MIM Contour ProtegeAI medical AI product profile

MIM auto-contouring software that uses machine learning to generate anatomical contours for trained clinical users to review and edit.

Screenshot of the official MIM Contour ProtegeAI product page
Medical imaging and radiology

Best fit

Cancer centers already using MIM workflows or evaluating vendor-neutral auto-segmentation that can be commissioned inside radiation oncology QA processes.

Primary use case
AI auto-segmentation for radiation oncology contours, CT and MR structure generation, molecular radiotherapy contour support, and MIM workflow automation
Audience
Radiation oncologists, dosimetrists, medical physicists, molecular radiotherapy teams, imaging software administrators, and cancer-center governance teams
Risk level
High
Pricing signal
MIM and GE HealthCare commercial terms vary; verify module licensing, cloud or local deployment, support, validation package, and regional availability.
Official sources
4 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating MIM Contour ProtegeAI as safe for a local clinical, operational, or research workflow.

Regulatory / FDAConfirm the exact FDA 510(k), product version, supported modality, structure set, intended use, and deployment geography because auto-segmentation claims vary by release.
PrivacyReview MIM workflow hosting, local or cloud deployment, DICOM and PHI handling, support access, retention, security controls, and contractual data-use language.
EvidenceEvaluate validation by anatomy and cancer site, local scanner performance, contour edit time, false contour risk, plan-quality effects, and physician acceptance.
WorkflowBest deployed with radiation oncologist review, dosimetry editing, physicist commissioning, structured exception handling, and documented fallback to manual contouring.

Where MIM Contour ProtegeAI fits

MIM Software announced FDA-cleared Contour ProtegeAI model updates for radiation oncology segmentation, additional structures, molecular radiotherapy enhancements, and flexible workflow implementation; FDA summaries state that automatically generated contours must be reviewed and edited as needed by trained users.

Not for: Unreviewed contour acceptance, unsupported anatomy or modality, or assuming older Contour ProtegeAI claims apply to the currently licensed version.

What to verify before using MIM Contour ProtegeAI

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products